Glycerogelatin-based ocular inserts of aceclofenac: Physicochemical, drug release studies and efficacy against prostaglandin E₂-induced ocular inflammation

References

• Bigi, A., Cojazzi, G., Panzavolta, S., Roveri, N., Rubini, K. (2002). Stabilization of gelatin films by crosslinking with genipin. Biomaterials.23:4827–32.
   PubMed Web of Science ®Google Scholar
• Bigi, A., Cojazzi, G., Panzavolta, S., Rubini, K., Roveri, N. (2001). Mechanical and thermal properties of gelatin films at different degree of glutaraldehyde crosslinking. Biomaterials. 22:763–8.
   PubMed Web of Science ®Google Scholar
• Charoo, N.A., Kohli, K., Ali, A., Anwer, A. (2003). Ophthalmic delivery of ciprofloxacin hydrochloride from different polymer formulations: in vitro and in vivo studies. Drug Dev Ind Pharm. 29:215–21.
   PubMed Web of Science ®Google Scholar
• Dandagi, P.M., Manvi, F.V., Patil, M.B., Mastiholimath, V.S., Rathod, R. (2004). Development and evaluation of ocular films of cromolyn sodium. Indian J Pharm Sci. 66:309–12.
   Google Scholar
• Davies, N.M. (2000). Biopharmaceutical considerations in topical ocular drug delivery. Clin Exp Pharmacol Physiol. 27:558–62.
   PubMed Web of Science ®Google Scholar
• De Carvalho, R.A., Grosso, C.R.F. (2004). Characterization of gelatin based films modified with transglutaminase, glyoxal and formaldehyde. Food Hydrocolloids. 18:717–26.
   Web of Science ®Google Scholar
• Gilhotra, R.M., Gilhotra, N., Mishra, D.N. (2009). Piroxicam bioadhesive ocular inserts: physicochemical characterization and evaluation in prostaglandin-induced inflammation. Curr Eye Res. 34:1065–73.
   PubMed Web of Science ®Google Scholar
• Gilhotra, R.M., Mishra, D.N. (2008). Alginate-chitosan film for ocular drug delivery: effect of surface cross-linking on film properties and characterization. Pharmazie. 63:576–9.
   PubMed Web of Science ®Google Scholar
• Gorle, A.P., Gattani, G.S. (2009). Design and Evaluation of Polymeric Ocular Drug Delivery System. Chem Pharm Bull. 57:914–9.
   PubMed Web of Science ®Google Scholar
• Grass, G.M., Robinson, J.R. (1984). Relationship of chemical structure to corneal penetration and influence of low viscosity solution on ocular bioavailability. J Pharm Sci. 73:1021–7.
   PubMed Web of Science ®Google Scholar
• Gupta, A.K., Madan, S., Majumdar, D.K., Maitra, A. (2000). Ketorolac entrapped in polymeric micelles: preparation, characterisation and ocular anti-inflammatory studies. Int J Pharm. 209:1–14.
   PubMed Web of Science ®Google Scholar
• Jayaprakash, S., James, C.C., Rajan, N.S.M.G., Saisivam, S., Nagarjan, M. (2000). Design and evaluation of ketorolac tromethamine ocuserts. Indian J Pharm Sci. 62:334–8.
   Google Scholar
• Karthikeyan, D., Bhowmick, M., Pandey, V.P., Nandhakumar, J., Sengottuvelu, S., Sonkar, S., Sivakumar, T. (2008). The concept of ocular inserts as drug delivery systems: an overview. Asian J Pharm. 2:192–200.
   Google Scholar
• Kaur, I.P., Smitha, R. (2002). Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm. 28:353–69.
   PubMed Web of Science ®Google Scholar
• Khan, S., Ali, A., Singhavi, D., Yeole, P. (2008). Controlled ocular delivery of acyclovir through rate controlling ocular insert of eudragit: a technical note. AAPS Pharm Sci Tech. 9:169–73.
   PubMed Web of Science ®Google Scholar
• Khanna, R., Agarwal, S.P., Ahuja, A. (1997). Preparation and evaluation of mucoadhesive buccal films of Clotrimazole for oral Candida infections. Indian J Pharm Sci. 59:299–305.
   Google Scholar
• Korsmeyer, R.W., Gurny, R., Doelker, E.M., Buri, P., Peppas, N.A. (1983). Mechanism of solute release from porous hydrophilic polymers. Int J Pharm. 15:25–35.
   Web of Science ®Google Scholar
• Malhotra, M., Majumdar, D.K. (2006). Aqueous, oil, and ointment formulations of ketorolac: efficacy against prostaglandin E2–induced ocular inflammation and safety: a technical note. AAPS Pharm Sci Tech. 7:E1–E6.
   PubMedGoogle Scholar
• Mundada, A.S., Shrikhande, B.K. (2006). Design and evaluation of soluble ocular drug insert for controlled release of ciprofloxacin hydrochloride. Drug Dev Ind Pharm. 32:443–8.
   PubMed Web of Science ®Google Scholar
• Mundada, A.S., Shrikhande, B.K. (2008). Formulation and evaluation of ciprofloxacin hydrochloride soluble ocular drug insert. Curr Eye Res. 33:469–75.
   PubMed Web of Science ®Google Scholar
• Nagura, M., Yokota, H., Ikeura, M., Gotoh, Y., Ohkoshi, Y. (2002). Structures and physical properties of cross-linked gelatin fibers. Polymer J. 34:761–6.
   Web of Science ®Google Scholar
• Ono, S.J., Abelson, M.B. (2005). Allergic conjunctivitis: update on pathophysiology and prospects for future treatment. J Allergy Clin Immunol. 115:118–22.
   PubMed Web of Science ®Google Scholar
• Orliac, O., Rouilly, A., Silvestre, F., Rigal, L. (2003). Effect of various plasticizers on the mechanical properties, water resistance and aging of thermo-moulded films made from sunflower proteins. Indust Corps and Prod. 18:91–100.
   Web of Science ®Google Scholar
• Pandit, J.K., Harikumar, S.L., Mishra, D.N., Balasubramaniam, S. (2003). Effect of physical cross linking on in vitro and ex vitro permeation of indomethacin from polyvinyl alcohol ocular inserts. Indian J Pharm Sci. 65:146–51.
   Google Scholar
• Patel, U., Chaudhary, K.A., Chotai, N.P., Nagada, C., Patel, K.N. (2008). Formulation and evaluation of indomethacin ophthalmic inserts. Indian J Pharm Educ Res. 42:348–52.
   Web of Science ®Google Scholar
• Rathore, K.S., Nema, R.K. (2009). Review on ocular inserts. Int J Pharm Tech Res. 1:164–9.
   Google Scholar
• Richards, F.M., Knowles, J.R (1968). Glutaraldehyde as a protein crosslinkage reagent. J Mol Biol. 37:231–233.
   PubMed Web of Science ®Google Scholar
• Ritger, P.L., Peppas, N.A. (1987). Simple equation for solute release Part 1. Fickian and nonfickian release from non-swellable devices in the form of slabs, spheres, cylinders or disks. J Control Release. 5:37–42.
   Google Scholar
• Rowe, R.C., Sheskey, P.J., Owen, S.C. (2006). Gelatin. In: Price, J.C., ed. Handbook of pharmaceutical excipients. UK: Pharmaceutical Press, USA: American Pharmacists Association, 295–98
   Google Scholar
• Saettone, M.F. (1993). Solid polymeric inserts/disks as ocular drug delivery systems. In: Edman, P., ed. Biopharmaceutics of ocular drug delivery. Boca Raton: CRC Press, 61–79
   Google Scholar
• Sankar, V., Chandrasekaran, A.K., Durga, S., Geetha, G., Ravichandran, V., Vijaya kumar, A., Raguraman, S., Geetha, G. (2006). Design and evaluation of diclofenac sodium ophthalmic inserts. Acta Pharma Sci. 48:5–10.
   Google Scholar
• Sood, R. (1999). Medical laboratory technology: methods and interpretations. New Delhi, India: Jaypee Brothers, 169–237.
   Google Scholar
• Spielmann, H. (1997). Ocular irritation. In: Castle, J.V., Gomez, M.J., ed. In vitro methods in pharmaceutical research. San Diego: Academic, 265–87.
   Google Scholar
• Sreenivas, S.A., Hiremath, S.P., Godbole, A.M. (2006). Ofloxacin ocular inserts: design, formulation and evaluation. Iranian J Pharmacol Ther. 5:159–62.
   Google Scholar
• Talebian, A., Kordestani, S.S., Dadashian, F., Rashidi, A., Montazer, M., Asghari, M. (2007). Study the properties of cross linked gelatin films with glutaraldehyde. World Applied Sci J. 2:575–81.
   Google Scholar
• Vandelli, M.A., Rivasi, F., Guerra, P., Forni, F., Arletti, R. (2001). Gelatin microspheres crosslinked D-L-glyceraldehyde as a potential drug delivery system: preparation, characterization, in vitro and in vivo studies. Int J Pharma. 215:175–84.
   PubMed Web of Science ®Google Scholar
• Velpandian, T., Bankoti, R., Humayun, S., Ravi, A.K., Kumari, S.S., Biswas, N.R. (2006). Comparative evaluation of possible ocular photochemical toxicity of fluoroquinolones meant for ocular use in experimental models. Ind J Exp Biol. 5:387.
   Google Scholar
• Wan, L.S.C., Heng, P.W.S., Wong, L.F. (1995). Matrix swelling: a simple model describing the extent of swelling of HPMC matrices. Int J Pharm. 116:195–8.
   Google Scholar